据新闻报道,Ginkgo Bioworks Holdings(DNA.N)今晚股价在夜盘交易中大幅下挫14.29%,其股价大跌引发了市场广泛关注。
公司此前公布的2024年第四季度财报数据令人失望,成为股价暴跌的主要原因。Ginkgo Bioworks Holdings在该季度每股亏损高达2美元,远超分析师预期的1.77美元亏损。此外,公司销售额4385万美元也未能达到市场预期的4446万美元。
尽管与上年同期相比,公司亏损和营收数据均有所改善,但业绩仍未达市场预期,令投资者对该公司未来增长前景失去信心,从而抛售该股股票。分析人士表示,如果公司下一季度业绩无法好转,其股价可能面临进一步下跌风险。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.